Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN ... today announced the pricing of a public offering of an aggregate of 3,703,703 of the Company’s ordinary ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener TipRanks is the ...

in an public offering. All of the shares of common stock (and/or Pre-funded Warrants) are to be sold by the Company. Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent for the ...

today announced that it priced its public offering of 5,000,000 shares of common stock at a price of $0.85 per share. The closing of the offering is expected to occur on or about January 10 ...

today announced the closing of its previously announced public offering of 5,000,000 shares of common stock at $0.85 per share for gross proceeds of approximately $4.25 million. Ladenburg Thalmann ...

Hoth Therapeutics (HOTH ... The company affirms that it has no plans for a public or private offering at this time. Hoth’s financial position remains robust, with a strong balance sheet that ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

Evrysdi was developed in collaboration with PTC Therapeutics PTCT and the SMA ... Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum ...

several local companies raised funds through public stock offerings. Larimar Therapeutics (NASDAQ: LRMR) of Bala Cynwyd raised $172.5 million in February through follow-on stock offerings to ...

Two small companies had initial public offerings in the stock market late in the year. Medicus Pharma in Conshohocken raised $4 million in November, and BriaCell Therapeutics raised $5.5 million ...